| Multicenter phase II trial of S-1 in patients with cytokine-refractory ... - UroToday |
|
|
UroToday This phase II multicenter trial was conducted to evaluate the activity and safety of S-1 in Japanese patients with metastatic renal cell carcinoma (mRCC). |